Domov › Skvamóznocelulárny karcinóm hlavy a krku › Indiana
Klinické štúdie Skvamóznocelulárny karcinóm hlavy a krku v štáte Indiana
13 štúdií pre Skvamóznocelulárny karcinóm hlavy a krku hľadá účastníkov v zariadeniach v štáte Indiana.
Mestá v štáte Indiana
Oficiálny text štúdie (anglicky)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- IU Simon Cancer Center, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #4, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05176483Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- UChicago Medicine Northwest Indiana, Crown Point
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06589804Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- IU Health North Hospital, Carmel
- UChicago Medicine Northwest Indiana, Crown Point
- Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis
- a 3 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT02734537A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Community Cancer Center North, Indianapolis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07602842Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- Baptist Health Floyd, New Albany
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT06532279ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
- IU Health Joe and Shelly Schwarz Cancer Center, Carmel
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 8. 2026 · NCT06915038A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 7. 2026 · NCT06150664A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- UChicago Medicine - Northwest Indiana, Crown Point
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
- Community Health Network, Inc, Indianapolis
- a 3 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT04389632Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593, Fort Wayne
- Community Health Network, Inc. /ID# 243011, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT05005403A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Fort Wayne
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 26. 5. 2026 · NCT06256588A Study of VET3-TGI in Patients With Solid Tumors
- Community Health Network, Indianapolis
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 7. 4. 2026 · NCT06444815A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Community Health Network, Indianapolis
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 11. 2025 · NCT05902988Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.